Comprehensive tumor profiling panel utilizing LBP, IHC, PCR, and FISH methods to characterize tumor biology. This integrated approach provides multi-level diagnostic information for precision oncology.
Manufactured by
China
Guangzhou LBP Medicine Science & Technology Co., Ltd, founded in 2005, is the first publicly listed company in China's pathological diagnosis sector (listed on SSE STAR Market in 2020). The company specializes in R&D and manufacturing of pathological diagnostic products, with core technologies including liquid-based cytology, PCR, FISH probe labeling, and IHC antibody screening. LBP holds 60+ patents including 15 invention patents, with 500+ registered products serving nearly 1,800 medical institutions nationwide. Products are CE certified and approved by BSI and Japan MHLW.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Fujirebio Diagnostics,Inc.
China · 3 relevant products
Rayto Life and Analytical Sciences Co., Ltd.
China · 1 relevant product
GENETRON HEALTH (BEIJING) CO., LTD
China · 2 relevant products
63 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 98 closest product alternatives
Fujirebio Diagnostics,Inc. · China
In vitro diagnostic test panel for detection of multiple tumor markers with simplified experimental workflow and reliable accuracy. The assay provides stable results suitable for cancer screening and monitoring.
Rayto Life and Analytical Sciences Co., Ltd. · China
Multi-analyte immunoassay for cancer screening and monitoring biomarkers. Supports oncology patient management and follow-up.
GENETRON HEALTH (BEIJING) CO., LTD · China
A comprehensive genomic profiling test for tumor patients providing information on 831 cancer-related genes in a single test. The integrated analysis results support precision targeted therapy selection for cancer patients.
95 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products